Alerts will be sent to your verified email
Verify Email
FISCHER
|
Fischer Medical
|
Fineotex Chemical
|
Camlin Fine Sciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
5.29 % | 21.66 % | -0.75 % |
|
5yr average Equity Multiplier
|
0.49 | 1.23 | 2.29 |
|
5yr Average Asset Turnover Ratio
|
0.4 | 0.96 | 0.81 |
|
5yr Avg Net Profit Margin
|
-4.14 % | 18.58 % | -0.61 % |
|
Price to Book
|
8.14 | 3.63 | 3.12 |
|
P/E
|
147.14 | 28.75 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
140.14 Days | 50.7 Days | 30.19 Days |
|
Inventory Days
|
33.45 Days | 38.72 Days | 107.15 Days |
|
Days Receivable
|
163.11 Days | 87.15 Days | 67.17 Days |
|
Days Payable
|
23.17 Days | 72.34 Days | 122.28 Days |
|
5yr Average Interest Coverage Ratio
|
12.88 | 110.39 | 2.4 |
|
5yr Avg ROCE
|
3.71 % | 27.86 % | 13.22 % |
|
5yr Avg Operating Profit Margin
|
6.78 % | 21.92 % | 12.42 % |
|
5 yr average Debt to Equity
|
-0.66 | 0.01 | 0.82 |
|
5yr CAGR Net Profit
|
n/a | 20.5 % | n/a |
|
5yr Average Return on Assets
|
-4.27 % | 17.65 % | -0.48 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
61.8 % | 62.88 % | 49.08 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 10.84 % |
|
Change in Promoter Holding (3 Yrs)
|
61.8 % | -2.09 % | 31.53 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | -2.38 % | -8.09 % |
|
Fischer Medical
|
Fineotex Chemical
|
Camlin Fine Sciences
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|